ROCKWELL MEDICAL, INC. 8-K

What Happened

• Rockwell Medical, Inc. filed an 8-K (Item 3.03) disclosing a certificate of amendment to implement a one-for-ten reverse stock split of its common stock, effective 12:01 a.m. ET on July 1, 2026. The reverse split was approved by stockholders at the June 12, 2026 annual meeting. The Common Stock will begin trading on a split-adjusted basis at the open on July 1, 2026 and will keep the Nasdaq symbol "RMTI" while being issued a new CUSIP (774374409).

Key Details

• Reverse split ratio: 1-for-10; each ten shares combined into one share automatically at the Effective Time.
• No fractional shares will be issued; holders entitled to fractional shares will receive cash in lieu (without interest), based on the Nasdaq closing price on June 30, 2026 (adjusted in good faith), subject to applicable withholding.
• Par value per share remains $0.0001 and is unchanged.
• Proportionate adjustments will be made, effective at the same time, to outstanding equity awards and reserved shares under equity plans, the conversion price and reserved shares for Series X Convertible Preferred Stock, and the exercise price and reserved shares under warrants.

Why It Matters

• The reverse split reduces the number of outstanding shares and increases the per-share price on a proportionate basis; it does not change a holder’s percentage ownership (except for cash-outs of fractional shares). Investors should note timing (effective July 1, 2026), the new CUSIP, and the cash-in-lieu treatment for fractional shares (based on June 30 closing price). Outstanding options, convertible preferred terms and warrants will be adjusted as described, which affects share counts and per-share exercise/conversion prices going forward.